Loading…

Unmasking efavirenz neurotoxicity: Time matters to the underlying mechanisms

Efavirenz is an anti-HIV drug that presents relevant short- and long-term central nervous system adverse reactions. Its main metabolite (8-hydroxy-efavirenz) was demonstrated to be a more potent neurotoxin than efavirenz itself. This work was aimed to understand how efavirenz biotransformation to 8-...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pharmaceutical sciences 2017-07, Vol.105, p.47-54
Main Authors: Grilo, Nádia M., João Correia, M., Miranda, Joana P., Cipriano, Madalena, Serpa, Jacinta, Matilde Marques, M., Monteiro, Emília C., Antunes, Alexandra M.M., Diogo, Lucília N., Pereira, Sofia A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Efavirenz is an anti-HIV drug that presents relevant short- and long-term central nervous system adverse reactions. Its main metabolite (8-hydroxy-efavirenz) was demonstrated to be a more potent neurotoxin than efavirenz itself. This work was aimed to understand how efavirenz biotransformation to 8-hydroxy-efavirenz is related to its short- and long-term neuro-adverse reactions. To access those mechanisms, the expression and activity of Cyp2b enzymes as well as the thiolomic signature (low molecular weight thiols plus S-thiolated proteins) were longitudinally evaluated in the hepatic and brain tissues of rats exposed to efavirenz during 10 and 36days. Efavirenz and 8-hydroxy-efavirenz plasma concentrations were monitored at the same time points. Cyp2b induction had a delayed onset in liver (p
ISSN:0928-0987
1879-0720
DOI:10.1016/j.ejps.2017.05.010